GSE193993 SSTR2 knockout 0 v 6 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE193993_SSTR2 knockout_0_v_6_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE193993_SSTR2 knockout_0_v_6_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE193993_SSTR2 knockout_0_v_6_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE193993_SSTR2 knockout_0_v_6_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

mir-100-let-7a-2-mir-125b-1 cluster host gene

Gene

MT-ATP6 pseudogene 1

Gene

tripartite motif containing 31

Gene

long intergenic non-protein coding RNA 1133

Gene

DiGeorge syndrome critical region gene 5

Gene

MBNL1 antisense RNA 1

Gene

MAP3K4 antisense RNA 1

Gene

NUP50 divergent transcript

Gene

long intergenic non-protein coding RNA 659

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    mir-100-let-7a-2-mir-125b-1 cluster host gene


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    tripartite motif containing 31


  • Gene

    long intergenic non-protein coding RNA 1133


  • Gene

    DiGeorge syndrome critical region gene 5


  • Gene

    MBNL1 antisense RNA 1


  • Gene

    MAP3K4 antisense RNA 1


  • Gene

    NUP50 divergent transcript


  • Gene

    long intergenic non-protein coding RNA 659

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.